1.
Blauvelt A, Han G, Tyring S, Soung J, Oh T, Davis L, Vanoorden V, Lebwohl M. Mean percent PASI improvement with bimekizumab in patients with moderate to severe plaque psoriasis: Pooled results from four phase 3/3b trials. J of Skin [Internet]. 2021Nov.5 [cited 2022Jul.7];5(6):s55. Available from: https://www.jofskin.org/index.php/skin/article/view/1406